Get the Stockscreener App
18.07
0.88%
-0.16
Optimizerx Corp stock is traded at $18.07, with a volume of 333.56K.
It is down -0.88% in the last 24 hours and up +40.19% over the past month.
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
See More
Previous Close:
$18.23
Open:
$18.37
24h Volume:
333.56K
Relative Volume:
1.03
Market Cap:
$335.47M
Revenue:
$62.81M
Net Income/Loss:
$-13.75M
P/E Ratio:
-22.59
EPS:
-0.8
Net Cash Flow:
$153.00K
1W Performance:
+4.75%
1M Performance:
+40.19%
6M Performance:
+251.56%
1Y Performance:
+116.67%
1-Day Range:
$17.68
$18.46
1-Week Range:
$16.53
$18.96
52-Week Range:
$3.78
$18.96
Optimizerx Corp Stock (OPRX) Company Profile
Name
Optimizerx Corp
Sector
Industry
Phone
248-651-6558
Address
260 CHARLES STREET, WALTHAM, MI
Compare OPRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
18.07 | 338.44M | 62.81M | -13.75M | 153.00K | -0.80 |
|
VEEV
Veeva Systems Inc
|
269.20 | 44.50B | 2.86B | 780.66M | 1.19B | 4.72 |
|
TEM
Tempus Ai Inc
|
75.86 | 12.80B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
67.94 | 12.81B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
89.33 | 7.63B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.88 | 6.67B | 906.14M | -52.62M | 89.62M | -0.3621 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Jul-25-24 | Resumed | B. Riley Securities | Buy |
| Apr-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Feb-02-23 | Resumed | B. Riley Securities | Buy |
| Nov-01-22 | Initiated | Stifel | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Outperform |
| Oct-18-21 | Resumed | B. Riley Securities | Buy |
| Apr-13-21 | Initiated | RBC Capital Mkts | Outperform |
| Jan-03-19 | Initiated | William Blair | Outperform |
View All
Optimizerx Corp Stock (OPRX) Latest News
How institutional ownership impacts OptimizeRx Corporation stockJuly 2025 Setups & Safe Swing Trade Setup Alerts - Newser
Published on: 2025-08-30 08:58:06 - Newser
Is OptimizeRx Corporation stock bottoming outMarket Activity Report & Free Daily Entry Point Trade Alerts - Newser
What Fibonacci levels say about OptimizeRx Corporation reboundPortfolio Gains Report & Long Hold Capital Preservation Plans - Newser
What indicators show strength in OptimizeRx CorporationQuarterly Portfolio Report & Reliable Price Breakout Alerts - Newser
Relative strength of OptimizeRx Corporation in sector analysis2025 Support & Resistance & High Conviction Buy Zone Picks - Newser
Is it time to cut losses on OptimizeRx CorporationMarket Movement Recap & Stepwise Trade Signal Implementation - Newser
Real time breakdown of OptimizeRx Corporation stock performanceWeekly Trend Report & High Conviction Buy Zone Picks - Newser
Real time pattern detection on OptimizeRx Corporation stockInsider Buying & Free Verified High Yield Trade Plans - Newser
Can OptimizeRx Corporation recover in the next quarterWeekly Profit Recap & Fast Moving Stock Trade Plans - Newser
Applying Elliott Wave Theory to OptimizeRx CorporationTreasury Yields & Daily Oversold Stock Bounce Ideas - Newser
Real time scanner hits for OptimizeRx Corporation explainedJuly 2025 Big Picture & High Return Stock Watch Alerts - Newser
Short interest data insights for OptimizeRx CorporationJuly 2025 Review & Low Risk High Win Rate Stock Picks - Newser
What to expect from OptimizeRx Corporation in the next 30 days2025 Pullback Review & AI Driven Price Forecasts - Newser
How to escape a deep drawdown in OptimizeRx CorporationJuly 2025 Gainers & Free Safe Entry Trade Signal Reports - Newser
Detecting price anomalies in OptimizeRx Corporation with AIWeekly Profit Recap & Verified Momentum Stock Watchlist - Newser
Chart based analysis of OptimizeRx Corporation trendsGap Down & Fast Moving Stock Watchlists - Newser
Using flow based indicators on OptimizeRx CorporationTrade Exit Report & Weekly High Conviction Trade Ideas - Newser
Chart overlay techniques for tracking OptimizeRx CorporationJuly 2025 Earnings & Reliable Momentum Entry Alerts - Newser
Is OptimizeRx Corporation stock entering bullish territoryEarnings Miss & Real-Time Sentiment Analysis - Newser
Earnings visualization tools for OptimizeRx CorporationQuarterly Performance Summary & Technical Pattern Based Signals - Newser
How moving averages guide OptimizeRx Corporation tradingWall Street Watch & Reliable Intraday Trade Alerts - Newser
Optimizerx's 15min chart: RSI Oversold, KDJ Golden Cross Signal Triggered - AInvest
Quantitative breakdown of OptimizeRx Corporation recent moveTrade Analysis Report & AI Powered Buy/Sell Recommendations - Newser
Published on: 2025-08-28 03:05:50 - Newser
OptimizeRx Corporation’s volatility index tracking explainedRate Cut & Weekly Chart Analysis and Trade Guides - Newser
Is OptimizeRx Corporation stock reversal real or fake2025 Institutional Moves & Fast Exit and Entry Strategy Plans - Newser
Visual analytics tools that track OptimizeRx Corporation performanceMarket Trend Review & Weekly Momentum Stock Picks - Newser
What the charts say about OptimizeRx Corporation todayPortfolio Update Summary & Safe Capital Investment Plans - Newser
Optimizerx Corp Stock (OPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Optimizerx Corp Stock (OPRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Lang James Paul | Director |
Mar 14 '25 |
Buy |
7.60 |
321,408 |
2,443,761 |
389,452 |
| Silvestro Stephen L | Chief Commercial Officer |
Mar 01 '25 |
Option Exercise |
0.00 |
1,928 |
0 |
121,886 |
| Odence-Ford Marion | Chief Legal Officer & CHRO |
Mar 01 '25 |
Option Exercise |
0.00 |
771 |
0 |
70,544 |
| KLEMA CATHY | Director |
Feb 02 '25 |
Option Exercise |
0.00 |
5,109 |
0 |
11,752 |
| Odence-Ford Marion | General Counsel and CCO |
Dec 19 '24 |
Option Exercise |
0.00 |
3,927 |
0 |
28,383 |
| Silvestro Stephen L | Chief Commercial Officer |
Dec 19 '24 |
Option Exercise |
0.00 |
6,546 |
0 |
83,424 |
| Besch Doug | Chief Product Officer |
Dec 19 '24 |
Option Exercise |
0.00 |
1,964 |
0 |
12,160 |
| Stelmakh Edward | CFO/COO |
Dec 19 '24 |
Option Exercise |
0.00 |
5,237 |
0 |
38,603 |
| FEBBO WILLIAM J | CEO |
Dec 12 '24 |
Buy |
5.01 |
20,000 |
100,220 |
601,253 |
| Odence-Ford Marion | General Counsel and CCO |
Nov 08 '24 |
Option Exercise |
0.00 |
1,785 |
0 |
24,980 |
2.73%
5.64%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):